Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Pharma
GSK questions Gilead's potential dominance of the PrEP market
A couple of aspects with Gilead's lenacapavir have GSK's execs thinking they can compete in the long-acting PrEP market for HIV.
Angus Liu
Feb 6, 2025 2:20pm
Investors sue GSK, claiming company misled them on Zantac
Feb 6, 2025 8:05am
GSK raises long-term sales goal—again—despite vaccines woes
Feb 5, 2025 11:06am
Merck, Pfizer among pharmas commemorating World Cancer Day 2025
Feb 4, 2025 11:52am
Top 10 most anticipated drug launches of 2025
Jan 27, 2025 3:00am
JPM25: CEOs encourage 'transparency' amid US anti-vaccine push
Jan 14, 2025 4:01pm
